Zobrazeno 1 - 10
of 321
pro vyhledávání: '"Takehiko Fujisawa"'
Autor:
Misuzu Fujita, PhD, Kengo Nagashima, PhD, Takashi Uno, MD, PhD, Hideyuki Hashimoto, MD, PhD, Kiminori Suzuki, MD, PhD, Tokuzo Kasai, MD, PhD, Kazuya Yamaguchi, MD, PhD, Yoshihiro Onouchi, MD, PhD, Daisuke Sato, PhD, Takehiko Fujisawa, MD, PhD, Akira Hata, MD, PhD
Publikováno v:
Advances in Radiation Oncology, Vol 9, Iss 8, Pp 101555- (2024)
Purpose: Hypofractionated radiation therapy (RT) was recommended for several cancer sites to reduce outpatient visits during the COVID-19 pandemic. This study aimed to identify the impact of the pandemic on hypofractionated RT for breast cancer in Ja
Externí odkaz:
https://doaj.org/article/d2d623bcb5eb44c1880e1a36c8289394
Autor:
Teruaki Mizobuchi, Akihiro Nomoto, Hironobu Wada, Naoyoshi Yamamoto, Mio Nakajima, Takehiko Fujisawa, Hidemi Suzuki, Ichiro Yoshino
Publikováno v:
Radiation Oncology, Vol 18, Iss 1, Pp 1-8 (2023)
Abstract Purpose This study aimed to compare the outcomes of patients with ground-grass opacity (GGO)-dominant non-small cell lung cancer (NSCLC) who were treated with carbon ion radiotherapy (CIRT) versus segmentectomy. Methods A retrospective revie
Externí odkaz:
https://doaj.org/article/729fc7024fad4b3caf9708bb2ea40c61
Autor:
Misuzu Fujita, Hideyuki Hashimoto, Kengo Nagashima, Kiminori Suzuki, Tokuzo Kasai, Kazuya Yamaguchi, Yoshihiro Onouchi, Daisuke Sato, Takehiko Fujisawa, Akira Hata
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-10 (2023)
Abstract Various countries have reported a decrease in breast cancer surgeries during the coronavirus disease 2019 (COVID-19) pandemic; however, inconsistent results have been reported in Japan. This study revealed changes in the number of surgeries
Externí odkaz:
https://doaj.org/article/fdffa066985241e39f74370890eedd68
Autor:
Misuzu Fujita, Shigeru Kusumoto, Itsuko Ishii, Tadashi Iwata, Takehiko Fujisawa, Masaya Sugiyama, Akira Hata, Masashi Mizokami
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-10 (2022)
Abstract There is no universal recommendation for managing the reactivation of HBV in patients with resolved HBV infection treated with anti-CD20 monoclonal antibodies for B-cell non-Hodgkin lymphoma. This study compared the cost-effectiveness of two
Externí odkaz:
https://doaj.org/article/cfd54a82131f49c68166f7fcec5da841
Publikováno v:
PLoS ONE, Vol 15, Iss 8, p e0238474 (2020)
ObjectivesA sufficient screening rate is indispensable to optimize the positive impact of colorectal cancer (CRC) screening. This study aimed to evaluate the effect of an additional outreach of providing an opportunity to obtain a kit for fecal immun
Externí odkaz:
https://doaj.org/article/f875916e2fb2431e8ed47f1e6ed6c41d
Autor:
Mio Nakajima, Naoyoshi Yamamoto, Kazuhiko Hayashi, Masataka Karube, Daniel K Ebner, Wataru Takahashi, Makoto Anzai, Kenji Tsushima, Yuji Tada, Koichiro Tatsumi, Tadaaiki Miyamoto, Hiroshi Tsuji, Takehiko Fujisawa, Tadashi Kamada
Publikováno v:
Radiation Oncology, Vol 12, Iss 1, Pp 1-9 (2017)
Abstract Background Lung cancer is frequently complicated by interstitial lung disease (ILD). Treatment protocols for lung cancer patients with ILD have not been established; surgery, chemotherapy, and radiotherapy can all cause acute exacerbation of
Externí odkaz:
https://doaj.org/article/b64e4d829156449699acd5b0e0ed0c6a
Autor:
Misuzu Fujita, Kengo Nagashima, Kiminori Suzuki, Tokuzo Kasai, Hideyuki Hashimoto, Kazuya Yamaguchi, Yoshihiro Onouchi, Daisuke Sato, Takehiko Fujisawa, Akira Hata
Publikováno v:
Journal of Cancer Research and Clinical Oncology.
Autor:
Misuzu Fujita, Kazuya Yamaguchi, Kengo Nagashima, Kiminori Suzuki, Tokuzo Kasai, Hideyuki Hashimoto, Yoshihiro Onouchi, Daisuke Sato, Takehiko Fujisawa, Akira Hata
Publikováno v:
Cancer Epidemiology. 85:102391
Autor:
Misuzu Fujita, Shigeru Kusumoto, Itsuko Ishii, Tadashi Iwata, Takehiko Fujisawa, Masaya Sugiyama, Akira Hata, Masashi Mizokami
Publikováno v:
Scientific reports. 12(1)
There is no universal recommendation for managing the reactivation of HBV in patients with resolved HBV infection treated with anti-CD20 monoclonal antibodies for B-cell non-Hodgkin lymphoma. This study compared the cost-effectiveness of two commonly
Autor:
Kengo Nagashima, Kiminori Suzuki, Sho Takahashi, Akira Hata, Misuzu Fujita, Takehiko Fujisawa
Publikováno v:
Respirology. 25:191-197
Background and objective Improved detectability of chronic obstructive pulmonary disease (COPD) using a handheld flow meter (HFM) with symptom-based questionnaires has not been sufficiently evaluated. This study aimed to identify the benefit of using